ArticleBMC veterinary research2025
In vitro and in vivo effectiveness of essential oils against coccidia in Black Livorno chickens.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Insights into Non-Antibiotic Alternative and Emerging Control Strategies for Chicken Coccidiosis.Animals : an open access journal from MDPI · 2026Review
- Exploring the effects of phenolic compounds and essential oils in poultry: A sustainable strategy to combat Salmonella biofilm infections.Poultry science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoccidiosis remains a major challenge in poultry farming due to the drug-resistance phenomena in Eimeria strains and the possible risk of accumulation of anticoccidial residues in poultry-derived products. Essential oils (EOs) and their bioactive constituents are being considered for their potential role as alternative control strategies. The present study evaluated the in vitro efficacy of thymol, carvacrol, cinnamic aldehyde, eugenol, and a commercial EO blend (namely Energy Poultry, EP) against Eimeria spp., as well as the in vivo efficacy of thymol and EP (supplemented at 5 mg/kg and 50 mg/kg of feed, respectively) in growing chickens.
resultsIn vitro assays demonstrated that thymol and carvacrol significantly disrupted oocyst integrity and inhibited sporulation at concentrations ≥ 2%, with maximal degeneration rates of 96% and 90%, respectively, at 10%. Cinnamic aldehyde reduced sporulation by 79%, whereas eugenol showed minimal efficacy. The potential synergistic effect between carvacrol and cinnamic aldehyde of EP resulted in a marked reduction in oocyst viability (~ 90%). Based on these findings, thymol and EP were selected for in vivo evaluation in a native Italian egg-type chicken breed, the Black Livorno. Despite not significant, dietary supplementation (thymol: 5 mg/kg; EP: 50 mg/kg) led to a reduction in oocyst per gram (OPG) values from day 78 onward compared to the control group in which the highest oocyst excretion persisting for an extended period. Growth performance (average daily gain and feed conversion ratio) was not affected, indicating no adverse effects of thymol and EP supplementation. Despite the presence of highly pathogenic Eimeria species (E. tenella, E. necatrix), no clinical signs were observed, probably due to the possible low parasitic burden and breed's inherent resistance.
conclusionsThe obtained findings suggest that while evaluated EO constituents exhibited promising anticoccidial effects in vitro, their in vivo efficacy may be dose-dependent, influenced by infection pressure and host factors. Further research is warranted to optimise tested EOs inclusion levels and assess their long-term impact on coccidiosis control in poultry production systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.